Yixintang Pharmaceutical Group Co.Ltd(002727) (SZ Yixintang Pharmaceutical Group Co.Ltd(002727) , closing price: 23.52 yuan) announced on April 1 that on April 1, 2022, the company received the notice from the actual controller, chairman and President Ruan Hongxian, director Guo Chunli, director and vice president Zhang Yong, director and vice president Ruan Guowei Xiansheng, vice president and Secretary of the board of directors Li Zhenghong. Based on the confidence in the future development prospect of the company and the recognition of the value of the company, The above managers increased their holdings of the company’s shares through centralized bidding through the trading system of Shenzhen Stock Exchange. On March 31, the above managers increased their holdings of the company’s shares through centralized bidding through the trading system of Shenzhen Stock Exchange, with a total increase of about 380000 shares.
From January to December 2021, Yixintang Pharmaceutical Group Co.Ltd(002727) the composition of operating revenue is: drug retail accounts for 84.67% and drug wholesale accounts for 13.19%.
